LEADER 01455nam  2200373Ia 450 
001 9910697092703321
005 20230902161905.0
035   $a(CKB)5470000002383971
035   $a(OCoLC)587646051
035   $a(EXLCZ)995470000002383971
100   $a20100330d1997      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $enonsterile semisolid dosage forms : scale-up and postapproval changes : chemistry, manufacturing, and controls : in vitro release testing and in vivo bioequivalence documentation
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,$d[1997]
215   $a1 electronic resource (30) pages
300   $a'SUPAC-SS."
300   $a"CMC 7."
320   $aIncludes bibliographical references (29).
517   $aGuidance for industry 
606   $aDrugs$xDosage forms$zUnited States$xTesting
606   $aDrugs$xTherapeutic equivalency$xDocumentation$zUnited States
615  0$aDrugs$xDosage forms$xTesting.
615  0$aDrugs$xTherapeutic equivalency$xDocumentation
712 02$aCenter for Drug Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910697092703321
996   $aGuidance for industry$93434577
997   $aUNINA